Congenital Hyperinsulinism
·MeSH: Hyperinsulinism
Prevalence
30.0 / 100K
5 drugs in development·2 companies·2 clinical trials
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Congenital Hyperinsulinism?
BioSniper tracks 5 drugs in development for Congenital Hyperinsulinism across 2 companies.
How many clinical trials target Congenital Hyperinsulinism?
There are 2 clinical trials targeting Congenital Hyperinsulinism tracked by BioSniper.
What is the prevalence of Congenital Hyperinsulinism?
The estimated prevalence of Congenital Hyperinsulinism is approximately 30.0 per 100,000 population.
Deep-dive into Congenital Hyperinsulinism
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis